<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Nintedanib on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/nintedanib/</link><description>Recent content in Nintedanib on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 08 Nov 2026 06:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/nintedanib/index.xml" rel="self" type="application/rss+xml"/><item><title>Progressive Pulmonary Fibrosis in SSc-ILD</title><link>https://rheumatologydigest.org/posts/ppf-systemic-sclerosis-expert-perspectives/</link><pubDate>Sun, 08 Nov 2026 06:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/ppf-systemic-sclerosis-expert-perspectives/</guid><description>No single definition of progression, no reliable predictor, no head-to-head trials. Start mycophenolate and escalate early when lung function falls.</description></item></channel></rss>